3-Feb-2026 6:00 AM CST - Business Wire Orthofix to Report Fourth Quarter and Full-Year 2025 Financial Results Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2025 financial results on Tuesday, February 24, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other location
4-Nov-2025 6:00 AM CST - Business Wire Orthofix Reports Third Quarter 2025 Financial Results Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the third quarter ended September 30, 2025, narrowed its full-year 2025 net sales guidance while maintaining the midpoint, and raised the low end of its adjusted EBITDA guidance. All pro forma measures contained within this release exclude the impact of the Companys decision to discontinue its M6 product lines. Highlights Third quarter
14-Oct-2025 6:00 AM CST - Business Wire Orthofix to Report Third Quarter 2025 Financial Results Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referenci
5-Aug-2025 6:00 AM CST - Business Wire Orthofix Reports Second Quarter 2025 Financial Results Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2025, and reaffirmed its full-year 2025 financial guidance. All pro forma measures contained within this release exclude the impact of the Companys decision to discontinue its M6 product lines. Highlights Second quarter 2025 net sales of $203.1 million, including sales from M6 artificial cervical and l
16-Jul-2025 6:00 AM CST - Business Wire Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate at the Canaccord Genuity 45th Annual Growth Conference in Boston. Management is scheduled to present on Wednesday, August 13, 2025 at 9:00 am Eastern Time. Interested parties can access the live and archived webcast of the presentation in the Events & Presentations section of the Orthofix Investor Relations Website at ir.or
15-Jul-2025 6:00 AM CST - Business Wire Orthofix to Report Second Quarter 2025 Financial Results Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025 before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing
6-May-2025 6:00 AM CST - Business Wire Orthofix Reports First Quarter 2025 Financial Results Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2025, updated its full-year 2025 net sales guidance, and reaffirmed its full-year 2025 non-GAAP adjusted EBITDA and positive free cash flow guidance. All pro forma measures contained within this release exclude the impact of the Companys decision to discontinue its M6-C and M6-L artificial disc product
15-Apr-2025 7:00 AM CST - Business Wire Orthofix to Report First Quarter 2025 Financial Results Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its first quarter 2025 financial results on Tuesday, May 6, 2025 before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the
25-Feb-2025 6:00 AM CST - Business Wire Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the fourth quarter and full-year ended December 31, 2024, and provided full-year 2025 financial guidance. Highlights Record fourth quarter 2024 net sales of $215.7 million, an increase of 8% on a reported and constant currency basis compared to fourth quarter 2023 U.S. Spine Fixation1 net sales growth of 12% compared to fourth quarter 202
3-Feb-2026 6:00 AM CST - Business Wire Orthofix to Report Fourth Quarter and Full-Year 2025 Financial Results Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2025 financial results on Tuesday, February 24, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other location
4-Nov-2025 6:00 AM CST - Business Wire Orthofix Reports Third Quarter 2025 Financial Results Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the third quarter ended September 30, 2025, narrowed its full-year 2025 net sales guidance while maintaining the midpoint, and raised the low end of its adjusted EBITDA guidance. All pro forma measures contained within this release exclude the impact of the Companys decision to discontinue its M6 product lines. Highlights Third quarter
14-Oct-2025 6:00 AM CST - Business Wire Orthofix to Report Third Quarter 2025 Financial Results Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referenci
5-Aug-2025 6:00 AM CST - Business Wire Orthofix Reports Second Quarter 2025 Financial Results Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2025, and reaffirmed its full-year 2025 financial guidance. All pro forma measures contained within this release exclude the impact of the Companys decision to discontinue its M6 product lines. Highlights Second quarter 2025 net sales of $203.1 million, including sales from M6 artificial cervical and l
16-Jul-2025 6:00 AM CST - Business Wire Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate at the Canaccord Genuity 45th Annual Growth Conference in Boston. Management is scheduled to present on Wednesday, August 13, 2025 at 9:00 am Eastern Time. Interested parties can access the live and archived webcast of the presentation in the Events & Presentations section of the Orthofix Investor Relations Website at ir.or
15-Jul-2025 6:00 AM CST - Business Wire Orthofix to Report Second Quarter 2025 Financial Results Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025 before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing
6-May-2025 6:00 AM CST - Business Wire Orthofix Reports First Quarter 2025 Financial Results Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2025, updated its full-year 2025 net sales guidance, and reaffirmed its full-year 2025 non-GAAP adjusted EBITDA and positive free cash flow guidance. All pro forma measures contained within this release exclude the impact of the Companys decision to discontinue its M6-C and M6-L artificial disc product
15-Apr-2025 7:00 AM CST - Business Wire Orthofix to Report First Quarter 2025 Financial Results Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its first quarter 2025 financial results on Tuesday, May 6, 2025 before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the
25-Feb-2025 6:00 AM CST - Business Wire Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the fourth quarter and full-year ended December 31, 2024, and provided full-year 2025 financial guidance. Highlights Record fourth quarter 2024 net sales of $215.7 million, an increase of 8% on a reported and constant currency basis compared to fourth quarter 2023 U.S. Spine Fixation1 net sales growth of 12% compared to fourth quarter 202
